{"filings":[{"id":3018836,"accession_number":"0001493152-26-043717","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-09-22T20:30:17+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Caring Brands appoints CFO Meadows and Chairman Wilson; prior CFO John departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian John ceased as Interim CFO, principal accounting officer, director and Chairman on Sept 16, 2026; no disagreement cited.","Dr. Glynn Wilson, CEO, appointed Chairman effective Sept 18, 2026.","Brian Meadows appointed full-time CFO and principal financial officer effective Sept 18, 2026; he remains a director but no longer qualifies as independent.","Consulting agreement with Myall Luna (Measures' company) amended to expand CFO services; monthly fee raised from $10,000 to $15,000.","John's vested stock options remain exercisable until original expiration; board approved new fee arrangement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2820396,"accession_number":"0001493152-26-042368","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-09-11T18:46:01+00:00","items":["3.02","7.01","9.01"],"status":"ready","headline":"Caring Brands raises $7.15M PIPE; pro forma equity $8.22M, seeks Nasdaq panel relief","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Second PIPE closing on 9/11/26: 2,549.9 Series B Preferred shares plus A/B warrants for 2,549,900 shares each; gross proceeds $2,549,900.","Cumulative PIPE: 7,149.9 Series B Preferred shares and warrants for 7,149,900 shares; gross proceeds $7,149,900 (initial $4.6M closed 9/1/26).","Pro forma stockholders' equity at 8/31/26 is $8,220,419 vs $2.5M Nasdaq Capital Market Equity Standard — $5,720,419 cushion.","Staff Delisting Determination received 7/15/26 for equity-rule noncompliance; filing submitted to Nasdaq Hearings Panel, with no assurance of reinstatement.","Series A Convertible Redeemable Preferred reclassified $3,852,686 from mezzanine to permanent equity via holder redemption waiver and Certificate amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2798636,"accession_number":"0001493152-26-042225","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-09-10T21:07:56+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Caring Brands appoints Brian R. Meadows as independent director; enters consulting pact","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian R. Meadows appointed independent director effective Sept 4, 2026; he is CFO of Jones Soda Co. since 2025.","Company entered consulting agreement with Myall Luna Ventures (Meadows is President) for financial/accounting services, $10k/month, term Sept 2, 2026 to Sept 1, 2027.","Director agreement grants annual options for 25,000 shares under Equity Incentive Plan, exercise price at market, 5-year term.","Meadows previously CFO of Trubar Inc. (2020-2024) and Atmofizer Technologies (2021-2026)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2614836,"accession_number":"0001493152-26-041165","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-09-02T13:14:41+00:00","items":["7.01","9.01"],"status":"ready","headline":"Caring Brands closes initial $4.6M of $9M private placement for marketing push","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initial closing of $4.6M in convertible preferred shares completed Sept 1, 2026 under $9M Purchase Agreement.","Additional $4.4M in subscription documents executed; funds expected to clear by Sept 4, 2026.","Upon clearing, company to issue 4,400 Series B Preferred shares plus warrants for up to 8.8M common shares.","Proceeds to fund domestic and international marketing campaigns and build proprietary salesforce.","CEO Dr. Glynn Wilson says moves should enable substantially faster revenue growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2599796,"accession_number":"0001493152-26-040985","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-09-01T18:20:54+00:00","items":["3.02","8.01"],"status":"ready","headline":"Caring Brands completes initial $4.6M private placement; expects $10.25M equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initial closing issued 4,600 Series B Preferred shares at $1,000 each for $4.6M gross proceeds.","Warrants to purchase up to 4.6M shares each (Series A at $0.825, Series B at $0.95) issued.","Series B Preferred convertible into 6,571,428 common shares at $0.70 per share.","Additional $4.4M expected by Sept 4, 2026; total equity expected ~$10.25M.","Amended Series A certificate eliminated redemption right; company expects Nasdaq $2.5M equity compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2468636,"accession_number":"0001493152-26-040102","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-08-25T21:28:42+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"Caring Brands enters up to $11M private placement of Series B convertible preferred and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issues up to 11,000 Series B Preferred shares at $1,000 each for gross proceeds up to $11,000,000.","Series B converts at $0.70/share, accrues 8% annual dividend payable in cash or stock; liquidation pari passu with Series A.","Warrants cover 22M common shares: 11M at $0.825 and 11M at $0.95, both 5-year, full-ratchet anti-dilution.","Exchange cap of 19.99% of outstanding common until stockholder approval; no variable-rate deals or stock splits for 120 days.","Registration statement to be filed within 30 trading days, effective within 60-90 days; liquidated damages up to 6% if delayed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2108476,"accession_number":"0001493152-26-036419","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-08-06T21:28:42+00:00","items":["8.01","9.01"],"status":"ready","headline":"Caring Brands announces five issued U.S. patents for Hair Enzyme Booster and Photocil; Nasdaq delisting appeal ongoing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Five issued U.S. patents now protect two core platforms: Hair Enzyme Booster (4 patents) and Photocil (1 patent).","Hair Enzyme Booster targets $1.8B+ market; up to 50-60% of minoxidil users have low scalp enzyme levels.","Photocil targets $20B+ dermatology market; addresses psoriasis and vitiligo patients needing safe phototherapy.","Company is not in compliance with Nasdaq stockholders' equity requirement; delisting determination appealed.","Commercialization strategy includes B2B licensing, DTC via Amazon, and existing partnership with Taisho Pharmaceutical."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1721037,"accession_number":"0001493152-26-033777","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-07-17T21:00:22+00:00","items":["3.01"],"status":"ready","headline":"Nasdaq denies Caring Brands' continued listing; equity below $2.5M threshold","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of $2,091,324 was below Nasdaq's $2.5M minimum; alternative standards also not met.","Nasdaq Staff denied continued listing on July 15, 2026, citing lack of definitive financing agreement for compliance plan.","Company intends to request a hearing by July 22, 2026; timely request stays suspension pending Panel decision.","If no hearing, trading in CABR common stock will be suspended at open on July 24, 2026, and Nasdaq will file Form 25-NSE.","No assurance that Panel will grant continued listing or that company will regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1693997,"accession_number":"0001493152-26-033575","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-07-16T21:12:45+00:00","items":["1.01","3.02","3.03","9.01"],"status":"ready","headline":"Caring Brands raises $400K in PIPE; issues Series A Preferred convertible at $0.40/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds $400K from 443 Series A Preferred shares (stated value $1,000) and 1,052,632 warrants at $0.40 exercise.","$150K of proceeds used to repurchase 150K common shares from BK Investments LLC (owned by Chairman/acting CFO Brian John).","Series A Preferred carries 8% dividend payable in cash or common stock; convertible at $0.40 per share.","Warrants exercisable immediately for 5 years; beneficial ownership limitation of 4.99%.","Amendment to Certificate of Designation increases authorized Series A shares from 4,000 to 4,500."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1639756,"accession_number":"0001493152-26-033213","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-07-14T21:27:31+00:00","items":["5.07"],"status":"ready","headline":"Caring Brands shareholders approve three proposals at special meeting","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Proposal 1 (Additional Investment Right) approved: 4,457,375 for, 155,999 against.","Proposal 2 (Share Issuance) approved: 4,456,776 for, 156,598 against.","Proposal 3 (Increase Authorized Shares) approved: 5,118,645 for, 498,052 against.","Quorum of 61.79% of outstanding shares (5,617,697) was present at the July 9, 2026 meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":759758,"accession_number":"0001493152-26-026533","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-06-01T12:05:42+00:00","items":["7.01","9.01"],"status":"ready","headline":"Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.","SCPL's existing sublicense partners include Eris, Dr. Reddy's, Cipla, Dabur, Glenmark for Hair Enzyme Booster in multiple Asian and Middle Eastern markets.","Photocil (commercialized as Photofirst by Eris) is a patented topical for vitiligo, psoriasis, and atopic dermatitis.","Hair Enzyme Booster is a first-of-its-kind topical that increases SULT1A1 enzyme to convert Minoxidil into active form for hair growth.","CEO Glynn Wilson stated the expanded agreement reflects confidence in SCPL and aims to improve revenue stream."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":749278,"accession_number":"0001493152-26-026451","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-05-29T21:29:56+00:00","items":["8.01"],"status":"ready","headline":"Caring Brands corrects record date in proxy statement - May 14, not May 12","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Prior proxy statement (May 12, 2026) incorrectly listed May 12, 2026 as record date for annual meeting.","Correct record date is May 14, 2026; only stockholders of record on that date can vote.","Company will file a revised definitive proxy statement to correct the error.","All other information in the proxy statement remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97251,"accession_number":"0001493152-26-016171","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Caring Brands receives Nasdaq delisting notice for equity shortfall; stock continues trading","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of $2,091,324 reported in FY2025 10-K, below Nasdaq's $2.5M minimum requirement.","Company has 45 days (until May 22, 2026) to submit a compliance plan to Nasdaq.","If plan accepted, Nasdaq may grant up to 180 days (until Oct 4, 2026) to regain compliance.","Common stock continues trading under symbol CABR with no immediate delisting effect.","Company plans to take measures but cannot assure plan acceptance or compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111861,"accession_number":"0001493152-26-013808","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["3.03","5.02","5.03","9.01"],"status":"ready","headline":"Caring Brands reduces shareholder quorum to 33.33% and names Brian John interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bylaw amendment cuts quorum for shareholder meetings from majority to 33.33% of outstanding shares.","Brian John, current Chairman and CIO, appointed Interim CFO effective March 30, 2026.","No material changes to John's compensation in connection with the appointment.","Amendment to Bylaws filed as Exhibit 3.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111860,"accession_number":"0001493152-26-012418","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["1.01","3.02","3.03","9.01"],"status":"ready","headline":"Caring Brands closes $3.6M PIPE with Series A Preferred and warrants; redeems 6.25M insider shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 3,789.74 Series A Preferred shares (stated value $1,000 each) and 9,473,685 warrants at $0.40 exercise price for $3.6M gross.","$3.075M of proceeds used to buy back 6,250,000 common shares from CEO, Chairman, and NovoDX; shares outstanding drop from 14.76M to 8.51M.","Series A Preferred pays 8% dividend (cash or common stock) and is convertible into common at $0.40 per share.","Purchaser receives additional investment right (AIR) to buy up to $4.0M of same securities at a discount to market price.","Warrants are exercisable for 5 years, with a 4.99% beneficial ownership limitation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111859,"accession_number":"0001493152-26-004846","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Caring Brands receives two U.S. patents for hair enzyme booster technology","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Two new U.S. patents granted Jan 2026 covering methods to increase sulfotransferase enzyme activity for topical hair loss treatments.","Patents strengthen IP portfolio for Hair Enzyme Booster, currently generating revenue via direct U.S. sales and international licensees.","CEO Dr. Glynn Wilson says patents validate scientific foundation and enhance competitive moat for hair and skin health strategy.","Company expects to provide further updates on product development, distribution expansion, and leveraging growing patent portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111858,"accession_number":"0001493152-26-001128","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-01-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Caring Brands CFO Tyler Moore resigns; search for successor underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tyler Moore resigned as CFO on January 5, 2026, not due to any disagreement with the company.","Board has commenced a search to fill the CFO position; expects to appoint a successor in near term.","Interim financial and reporting functions will be managed by existing team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111857,"accession_number":"0001493152-26-000286","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-01-05T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Caring Brands enters exclusive global license for Emesyl nausea relief product","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.","8% royalty on net sales; potential to earn 7% of Itonis equity per $200k in sales.","License may terminate if sales ≤$25k for four consecutive quarters after launch.","Global nausea treatment market projected >$6.23B in 2025, per QY Research.","CEO notes expansion of health/wellness portfolio; further updates expected on timelines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128490,"accession_number":"0001493152-25-023919","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Caring Brands raises $4M in IPO, lists on Nasdaq under 'CABR'","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,000,000 shares at $4.00; gross proceeds $4M, net ~$3.23M.","Granted underwriter 45-day option for up to 150,000 additional shares at $4.00.","Issued underwriter warrant for 30,000 shares (exercisable at $4.00 for 5 years).","Stock began trading on Nasdaq Capital Market on Nov 13, 2025; moved from OTCQB.","Proceeds for working capital, marketing, product sales, and debt repayment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}